Timothy J. Eberlein

11.8k citations
200 papers · 10k · 2 hit papers · h-index 50

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune cells in cancer
    • Breast Cancer Treatment Studies

Papers in

    • Immunotherapy and Immune Responses 58
    • T-cell and B-cell Immunology 32
    • Breast Cancer Treatment Studies 37

Timothy J. Eberlein

193 papers receiving 9.5k citations

Timothy J. Eberlein's Hit Papers

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer 2017 · 301 citations
3010+8+16Years since publication4008001.2k

Peers

Timothy J. Eberlein
Comparison fields: 5 of 135
  • Immunology 3.2k
  • Cancer Research 1.7k
  • Oncology 2.7k
  • Pathology and Forensic Medicine 659
  • Pulmonary and Respiratory Medicine 992
Replace David J. Liewehr with:
David J. Liewehr United States
John T. Vetto United States
Giorgos Constantine Karakousis United States
Brian J. Czerniecki United States
Russell S. Berman United States
Frances A. Collichio United States
Ava Kwong Hong Kong
David W. Ollila United States
Sarkis H. Meterissian Canada
Timothy R. Donahue United States
Timothy J. Eberlein relative to David J. Liewehr United States David J. Liewehr's profile →
Citations per field
00.5×2×3.5×
David J. Liewehr · 1×
Citations per year

Countries citing papers authored by Timothy J. Eberlein

Since Specialization
Citations

This map shows the geographic impact of Timothy J. Eberlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Eberlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Eberlein more than expected).

Fields of papers citing papers by Timothy J. Eberlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy J. Eberlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Eberlein. The network helps show where Timothy J. Eberlein may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy J. Eberlein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy J. Eberlein Line = papers co-authored together Timothy J. Eberlein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma
Hit paper breakdown →
20021257
2 2013518
3 1994409
4 2009376
5
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer
Hit paper breakdown →
2017301
6 1996283
7 2007267
8 1995254
9 2010237
10 1994182
11 2007163
12
HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer.
1994152
13 2012147
14 2018144
15 2008143
16
Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes.
2001140
17 2006129
18 1995127
19 1991126
20 2001123

About Timothy J. Eberlein

Timothy J. Eberlein is a scholar working on Immunology, Cancer Research, Oncology, Pathology and Forensic Medicine and Surgery, having authored 200 papers that have together received 10k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (58 papers), Breast Cancer Treatment Studies (37 papers), T-cell and B-cell Immunology (32 papers), Breast Lesions and Carcinomas (13 papers), Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Surgical Treatments (8 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Breast Implant and Reconstruction (7 papers). The work is most often cited by research in Immunology (3.2k citations), Cancer Research (1.7k citations), Oncology (2.7k citations), Pathology and Forensic Medicine (659 citations) and Pulmonary and Respiratory Medicine (992 citations). Timothy J. Eberlein has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Peter S. Goedegebuure, David C. Linehan, Hong‐Gu Joo, William E. Gillanders, Udaya K. Liyanage, Todd T. Moore, Yoshiyuki Tanaka, Julie A. Margenthaler, Rebecca Aft and George Earl Peoples. Their work appears in journals such as Annals of Surgery, Annals of Surgical Oncology, The Journal of Immunology, Surgery and The American Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact